In addition, l-arginine also attenuated APE-induced pulmonary hypertension through other mechanisms, including the modulation of NO synthesis and downregulation of MMP-2 and MMP-9 activities (Souza-Costa et al., 2005). The gene discussed is MMP2; the disease is pulmonary arterial hypertension.